Since the etiology of infectious mononucleosis is unknown, treatment remains symptomatic. Agents such as convalescent serum,1 corticotropin,2 cortisone derivatives,3,4 and γ-globulin5 have been used. Their efficacy has been equivocal and difficult to evaluate due to the lack of suitable controls in most instances and due to the variability of the severity of the disease. In 1960, Gothberg 6 reported dramatic improvement of the symptoms and fever in four patients with infectious mononucleosis when treated with chloroquine phosphate. The purpose of this study is evaluation of chloroquine phosphate in the treatment of infectious mononucleosis utilizing a double-blind technique.
Materials and Methods
All patients admitted to the USAF Hospital, Wright-Patterson Air Force Base, from October, 1961, to September, 1962, with suspected infectious mononucleosis were examined by us and were included in this study. Chloroquine phosphate (Aralen) 250 mg or an identical placebo tablet * was administered from a numbered
NORFLEET RG, RICKENBACH HF. Infectious Mononucleosis Treated With Chloroquine: A Double-Blind Study of 25 Cases. Arch Intern Med. 1964;113(3):412–414. doi:10.1001/archinte.1964.00280090098016
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: